Exploring Novel Non-Operative Treatments for Osteoarthritis: An Examination of Innovative Therapies

Osteoarthritis (OA) is a prevalent degenerative joint disease that significantly impacts the quality of life of millions worldwide, particularly the elderly. While conventional non-surgical treatments, such as NSAIDs, intra-articular injections, and physical therapy, provide symptomatic relief, thei...

Full description

Saved in:
Bibliographic Details
Main Authors: Piotr Robert Bakuła, Kamila Jałocha, Joanna Zygadło
Format: Article
Language:English
Published: Nicolaus Copernicus University in Toruń 2025-02-01
Series:Quality in Sport
Subjects:
Online Access:https://apcz.umk.pl/QS/article/view/58169
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823856471042949120
author Piotr Robert Bakuła
Kamila Jałocha
Joanna Zygadło
author_facet Piotr Robert Bakuła
Kamila Jałocha
Joanna Zygadło
author_sort Piotr Robert Bakuła
collection DOAJ
description Osteoarthritis (OA) is a prevalent degenerative joint disease that significantly impacts the quality of life of millions worldwide, particularly the elderly. While conventional non-surgical treatments, such as NSAIDs, intra-articular injections, and physical therapy, provide symptomatic relief, their long-term efficacy and safety remain limited. Recent advancements in understanding OA pathophysiology have spurred the development of innovative therapeutic strategies targeting disease progression. This review examines emerging pharmacological and regenerative approaches, including disease-modifying osteoarthritis drugs (DMOADs), biologics, and cell-based therapies. Cutting-edge technologies such as RNA interference, CRISPR/Cas9, and advanced regenerative medicine are also explored for their potential to revolutionize OA management. Additionally, the integration of novel therapies with traditional interventions is discussed, highlighting opportunities for a more personalized, multimodal approach to OA care. Despite significant progress, challenges such as translational hurdles, cost barriers, and long-term efficacy require further investigation. This review emphasizes the transformative potential of emerging therapies in addressing the unmet needs of OA patients and shaping future treatment paradigms.
format Article
id doaj-art-fa89c2494ce54264a04ae0c9fde6368b
institution Kabale University
issn 2450-3118
language English
publishDate 2025-02-01
publisher Nicolaus Copernicus University in Toruń
record_format Article
series Quality in Sport
spelling doaj-art-fa89c2494ce54264a04ae0c9fde6368b2025-02-12T08:26:14ZengNicolaus Copernicus University in ToruńQuality in Sport2450-31182025-02-013810.12775/QS.2025.38.58169Exploring Novel Non-Operative Treatments for Osteoarthritis: An Examination of Innovative TherapiesPiotr Robert Bakuła0https://orcid.org/0009-0002-8066-5688Kamila Jałocha1https://orcid.org/0009-0003-5734-5261Joanna Zygadło2https://orcid.org/0000-0001-5377-5254Międzyleski Specialist Hospital in Warsaw, Bursztynowa 2, 04-749 Warsaw, PolandMedical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland Osteoarthritis (OA) is a prevalent degenerative joint disease that significantly impacts the quality of life of millions worldwide, particularly the elderly. While conventional non-surgical treatments, such as NSAIDs, intra-articular injections, and physical therapy, provide symptomatic relief, their long-term efficacy and safety remain limited. Recent advancements in understanding OA pathophysiology have spurred the development of innovative therapeutic strategies targeting disease progression. This review examines emerging pharmacological and regenerative approaches, including disease-modifying osteoarthritis drugs (DMOADs), biologics, and cell-based therapies. Cutting-edge technologies such as RNA interference, CRISPR/Cas9, and advanced regenerative medicine are also explored for their potential to revolutionize OA management. Additionally, the integration of novel therapies with traditional interventions is discussed, highlighting opportunities for a more personalized, multimodal approach to OA care. Despite significant progress, challenges such as translational hurdles, cost barriers, and long-term efficacy require further investigation. This review emphasizes the transformative potential of emerging therapies in addressing the unmet needs of OA patients and shaping future treatment paradigms. https://apcz.umk.pl/QS/article/view/58169cartilage regenerationosteoarthritisdisease-modyfing osteoarthritis drugsemerging therapiespain managementcell-based therapies
spellingShingle Piotr Robert Bakuła
Kamila Jałocha
Joanna Zygadło
Exploring Novel Non-Operative Treatments for Osteoarthritis: An Examination of Innovative Therapies
Quality in Sport
cartilage regeneration
osteoarthritis
disease-modyfing osteoarthritis drugs
emerging therapies
pain management
cell-based therapies
title Exploring Novel Non-Operative Treatments for Osteoarthritis: An Examination of Innovative Therapies
title_full Exploring Novel Non-Operative Treatments for Osteoarthritis: An Examination of Innovative Therapies
title_fullStr Exploring Novel Non-Operative Treatments for Osteoarthritis: An Examination of Innovative Therapies
title_full_unstemmed Exploring Novel Non-Operative Treatments for Osteoarthritis: An Examination of Innovative Therapies
title_short Exploring Novel Non-Operative Treatments for Osteoarthritis: An Examination of Innovative Therapies
title_sort exploring novel non operative treatments for osteoarthritis an examination of innovative therapies
topic cartilage regeneration
osteoarthritis
disease-modyfing osteoarthritis drugs
emerging therapies
pain management
cell-based therapies
url https://apcz.umk.pl/QS/article/view/58169
work_keys_str_mv AT piotrrobertbakuła exploringnovelnonoperativetreatmentsforosteoarthritisanexaminationofinnovativetherapies
AT kamilajałocha exploringnovelnonoperativetreatmentsforosteoarthritisanexaminationofinnovativetherapies
AT joannazygadło exploringnovelnonoperativetreatmentsforosteoarthritisanexaminationofinnovativetherapies